SCHEMBL25390089

SCHEMBL25390089

CC(C)(C(=O)O)N1CCN(c2cccc(F)c2F)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ DRD2 P14416 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ TSHR P16473 2/20 0.42
▸ USP2 O75604 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ NOTUM Q6P988 1/20 0.41
▸ TTR P02766 1/20 0.41
▸ RBP4 P02753 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26238626 0.80 HSD11B1 (0.45) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL25388961 0.79 LMNA (0.40) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL1041891 0.78 SMN1; SMN2 (0.57) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL25390175 0.78 ALDH1A1 (0.61) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL12957576 0.77 TP53 (0.51) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
Trifluoroacetic Acid SCHEMBL1042184 0.75 HTR1A (0.48) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL8691136 0.74 KDM4E (0.52) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL13382891 0.74 DRD2 (0.53) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
Hydrochloric Acid SCHEMBL8692936 0.73 KDM4E (0.51) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1
SCHEMBL5716237 0.71 DRD2 (0.47) SMN1; SMN2KMT2AMAPK1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250280861-A1 SWEETENER COMPOSITIONS FIRMENICH INCORPORATED (US) 2025-09-11 — — US disclosed
EP-4472947-A1 SWEETENER COMPOSITIONS Firmenich Incorporated (US) 2024-12-11 — — EP disclosed
WO-2023172415-A1 SWEETENER COMPOSITIONS FIRMENICH INCORPORATED (US) 2023-09-14 — — WO disclosed
WO-2023172415-A1 SWEETENER COMPOSITIONS FIRMENICH INCORPORATED (US) 2023-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250280861-A1 SWEETENER COMPOSITIONS GPR119, TAS2R50, TAS2R30 SMN1; SMN2 1171/4885KMT2A 3161/4885MAPK1 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback